Rare diseases
Investigational molecules
Locations
Back to Poland1 clinical trial in Wodzislaw-Slaski, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on non-small cell lung cancer (NSCLC) treatment approaches. These studies explore innovative combination therapies involving immunotherapy and traditional chemotherapy methods.
Research evaluates the effectiveness of combining platinum-based chemotherapy with targeted antibody treatments, aiming to improve patient survival rates in various PD-L1 expression scenarios.
Innovative research investigating PD-L1 targeted therapies in combination with standard treatment protocols. These trials represent significant advances in personalized cancer treatment approaches.
Studies focus on determining optimal treatment combinations for different patient populations based on specific biomarker expressions.
Clinical investigations exploring advanced treatment protocols for both squamous and non-squamous lung cancer variants. Research aims to establish more effective first-line treatment options.
The research evaluates multiple treatment combinations to determine optimal therapeutic approaches for different patient subgroups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
